Showing 20 of 86 recruiting trials for “Carcinoma of esophagus”
Adaptive Neoadjuvant Therapy for Esophageal Cancer
👨⚕️ Tao Zhen Yu, MD, National Cancer Center/ Cancer Hospital &Shenzhen Hospital Chinese Academy of Medical Sciences and Peking Union Medical College📍 1 site📅 Started Mar 2028View details ↗
RecruitingNCT07464470 ↗
Comparison of Molecular-Genetic Concordance of the Primary Tumor and Brain Metastases of Gastroesophageal Cancers
👨⚕️ Alexey Tryakin, MD, PhD, professor, Blokhin's Russian Cancer Research Center📍 1 site📅 Started Apr 2026View details ↗
High-Flow Nasal Cannula for Preventing Hypoxia During Sedated Endoscopy in High-Risk Obstructive Sleep Apnea Patients
Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.
Phase II Study Evaluating Safety and Efficacy of Tislelizumab for Elderly Patients Unfit for Chemotherapy, With Advanced Esophageal Squamous-cell Carcinoma
Brachytherapy With Radiotherapy and Immunotherapy: Guided HDR Trial in Esophageal Squamous Cell Carcinoma
Clinical Study of Adbelimumab in the Adjuvant Treatment of Esophageal Squamous Cell Carcinoma.
Single Dose Investigator Initiated Pilot Study to Investigate CYTALUX (Pafolacianine) for Intraoperative Detection of Malignant Tissue in Subjects Undergoing Surgical Resection for Cancer.
👨⚕️ John Waters, M.D., University of Texas Southwestern Medical Center📍 1 site📅 Started Aug 2025View details ↗
64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer
RecruitingNCT07354295 ↗
Integrating Multimodal AI to Predict Treatment Response and Refine Risk Stratification in Esophageal Cancer （Radiogenomics-Esophagus）
Impact of Prehabilitation in Oncology Via Exercise- Esophageal (IMPROVE-Esophageal)
RecruitingNCT06597240 ↗
Home Monitoring During Chemoradiation
👨⚕️ Rudolf S.N. Fehrmann, MD, PhD, University Medical Center Groningen📍 1 site📅 Started May 2025View details ↗
Intra-tumoral (IT) Injection of vvDD-hIL2-2-RG-1 for Metastatic Gastrointestinal and Peritoneal Tumors
RecruitingNCT07054086 ↗
Patient Derived Organoids (PDOs) to Observe the Clinical Consistency of Personalized Neoadjuvant Therapy for Resectable Esophageal Squamous Cell Carcinoma
RecruitingNCT07114627 ↗
Impact of CES1 Genotype on Capecitabine Exposure in Cancer Patients
Multicenter Validation Trial of [18F]AlF-FAPI-74 for PET Imaging of Cancer-associated Fibroblasts Through Fibroblast Activation Protein Inhibitors (FAPI) in Different Tumor Types
RecruitingNCT07266363 ↗
Integrated Cf-miRNA and Exosomal miRNA Signature for Early Detection of Esophageal Squamous Cell Carcinoma
Effectiveness of Methods for Pyloric Drainage in esophagecTomY: Botox vs. Pyloromyotomy
Neoantigen Vaccines in Esophageal Squamous Cell Carcinoma
👨⚕️ zhenyu ding, MD, West China Hospital of Sichuan University, ChengDu, China📍 1 site📅 Started Oct 2024View details ↗
Oral TGF-beta Receptor I Inhibitor Vactosertib in SOC Chemoradiotherapy for Esophageal Adenocarcinoma
👨⚕️ Sakti Chakrabarti, MD, University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center📍 1 site📅 Started Sep 2024View details ↗
Page 1 of 5Next →
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →